[Congressional Record Volume 161, Number 40 (Tuesday, March 10, 2015)]
[Senate]
[Page S1394]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
SA 282. Ms. AYOTTE (for herself and Mr. Donnelly) submitted an
amendment intended to be proposed by her to the bill S. 178, to provide
justice for the victims of trafficking; which was ordered to lie on the
table; as follows:
At the appropriate place, insert the following:
SEC. ___. DEVELOPMENT OF BEST PRESCRIBING PRACTICES.
(a) Inter-agency Task Force.--Not later than 120 days after
the date of enactment of this Act, the Secretary of Health
and Human Services (referred to in this section as the
``Secretary''), in cooperation with the Secretary of Veterans
Affairs, the Secretary of Defense, and the Administrator of
the Drug Enforcement Administration, shall convene a Pain
Management Best Practices Inter-Agency Task Force (referred
to in this section as the ``task force'').
(b) Membership.--The task force shall be comprised of--
(1) representatives of--
(A) the Department of Health and Human Services;
(B) the Department of Veterans Affairs;
(C) the Department of Defense;
(D) the Drug Enforcement Administration;
(E) the Centers for Disease Control and Prevention;
(F) the Office of National Drug Control Policy;
(G) the Institute of Medicine;
(H) pain management professional organizations;
(I) the mental health treatment community;
(J) the addiction treatment community; and
(K) pain advocacy groups;
(2) the Director of the National Institutes of Health;
(3) physicians, dentists, and non-physician prescribers;
(4) pharmacists;
(5) experts in the fields of pain research and addiction
research; and
(6) other stakeholders, as the Secretary determines
appropriate.
(c) Duties.--The task force shall--
(1) not later than 180 days after the date on which the
task force is convened, develop best practices for pain
management and prescription pain medication prescribing
practices, taking into consideration--
(A) existing pain management research;
(B) recommendations from relevant conferences; and
(C) ongoing efforts at the State and local levels and by
medical professional organizations to develop improved pain
management strategies;
(2) solicit and take into consideration public comment on
the practices developed under paragraph (1), amending such
best practices if appropriate; and
(3) develop a strategy for disseminating information about
the best practices developed under paragraphs (1) and (2) to
prescribers, pharmacists, State medical boards, and other
parties, as the Secretary determines appropriate.
(d) Limitation.--The task force shall not have rulemaking
authority.
(e) Report.--Not later than 270 days after the date on
which the task force is convened, the task force shall submit
to Congress a report that includes--
(1) the strategy for disseminating best practices developed
under subsection (c);
(2) the results of a feasibility study on linking best
practices developed under paragraphs (1) and (2) of
subsection (c) to receiving and renewing registrations under
section 303(f) of the Controlled Substances Act (21 U.S.C.
823(f)); and
(3) recommendations on how to apply such best practices to
improve prescribing practices at medical facilities,
including medical facilities of the Veterans Health
Administration.
______